Authors:
Baker, LH
Bahnson, RR
Hanks, GE
Huben, RP
Kantoff, P
Kozlowski, JM
Kuettel, M
Lange, PH
Logothetis, C
Pow-Sang, JM
Roach, M
Sandler, H
Scardino, PT
Taylor, RJ
Urban, DA
Walsh, PC
Wilson, TG
Citation: Lh. Baker et al., NCCN Practice Guidelines for prostate cancer, ONCOLOGY-NY, 14(11A), 2000, pp. 111-119
Authors:
Williamson, SK
Lew, D
Miller, GJ
Balcerzak, SP
Baker, LH
Crawford, ED
Citation: Sk. Williamson et al., Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma - A Southwest Oncology Group study, CANCER, 88(5), 2000, pp. 1159-1165
Citation: Y. Sugawara et al., Splenic fluorodeoxyglucose uptake increased by granulocyte colony-stimulating factor therapy: PET imaging results, J NUCL MED, 40(9), 1999, pp. 1456-1462
Citation: Js. Biermann et Lh. Baker, Soft tissue sarcoma - Opening the door to advances in diagnosis and treatment, CANCER, 85(12), 1999, pp. 2497-2498
Authors:
Weiss, GR
Liu, PY
Alberts, DS
Peng, YM
Fisher, E
Xu, MJ
Scudder, SA
Baker, LH
Moore, DF
Lippman, SM
Citation: Gr. Weiss et al., 13-cis-retinoic acid or all-trans-retinoic acid plus inteferon-alpha in recurrent cervical cancer: A Southwest Oncology Group phase II randomized trial, GYNECOL ONC, 71(3), 1998, pp. 386-390